In the therapy, the patient’s immune cells cultures with cord blood stem cells and returns only the ‘educated’ immune cells to the patient’s circulation.
New research has revealed that a treatment called Stem Cell Educator therapy is safe and effective for treating type 1 and type 2 diabetes.
The therapy is believed to provide benefits because abnormalities in multiple types of immune cells contribute to the autoimmunity in type1 diabetes and the insulin resistance in type 2 diabetes.(Shutterstock)
The therapy is believed to provide benefits because abnormalities in multiple types of immune cells contribute to the autoimmunity in type1 diabetes and the insulin resistance in type 2 diabetes. Dr Yong Zhao, lead author of the study said, “Current mechanistic studies demonstrated that platelets and their released mitochondria may contribute to the long-lasting clinical improvement of islet beta cell function in type 1 and 2 diabetic patients after Stem Cell Educator therapy.”
He added, “This therapy can also be applied to treat other autoimmune and inflammation-related diseases.” The study was the Stem Cells Translational Medicine.